{"id":11929,"date":"2026-05-29T09:00:00","date_gmt":"2026-05-29T09:00:00","guid":{"rendered":"https:\/\/www.bedfont.com\/?p=11929"},"modified":"2026-05-21T11:10:50","modified_gmt":"2026-05-21T11:10:50","slug":"beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care","status":"publish","type":"post","link":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/","title":{"rendered":"Beyond symptom relief: What the 1 million inhaler milestone reveals about modern asthma care"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\">Almost 10 months after the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) released an updated joint guideline for asthma care and management, a major milestone has been hit. Over 1 million people are now using combination inhalers instead of relying solely on blue reliever inhalers, marking a major shift towards inflammation-focused asthma management.<sup>1<\/sup><\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>Why does this matter?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Previously, many people living with asthma relied on their blue reliever inhaler, which relieved symptoms, making them feel better quickly. The problem with this was that whilst symptoms were being addressed, the underlying airway inflammation, the main driver of their symptoms, was not being treated. If the inflammation is not treated, symptoms continue to recur, damaging quality of life and increasing over-reliance on medication.<sup>1<\/sup><\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>The problem with symptom-led asthma care.<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Patients who rely heavily on Short-Acting Beta-Agonist (SABA) inhalers (rescue inhalers) may report feeling well and believe that their asthma is well controlled because regular use of their inhaler keeps their symptoms at bay.<sup>1<\/sup> When, in reality, this reliance is masking the underlying issue: <strong>airway inflammation<\/strong>.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Asthma-1024x1024.png\" alt=\"Combination Asthma Inhaler - FeNO and modern asthma care\" class=\"wp-image-11931\" srcset=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Asthma-1024x1024.png 1024w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Asthma-300x300.png 300w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Asthma-150x150.png 150w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Asthma-768x768.png 768w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Asthma.png 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"523\" height=\"249\" src=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/image.png\" alt=\"Airway Inflammation Infographic\" class=\"wp-image-11732\" srcset=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/image.png 523w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/image-300x143.png 300w\" sizes=\"auto, (max-width: 523px) 100vw, 523px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Airway inflammation cannot always be felt, and if left untreated, it could lead to further exacerbations, including asthma attacks.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>The shift towards prevention-focused care.<sup>2<\/sup><\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The update to the guideline placed greater emphasis on treating the underlying inflammation rather than just the symptoms, demonstrating an evolution in asthma care. The updated guidance reflects:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Earlier anti-inflammatory treatment,<\/li>\n\n\n\n<li>Reduced SABA reliance,<\/li>\n\n\n\n<li>Prevention of exacerbations,<\/li>\n\n\n\n<li>More proactive asthma management.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The impact of this guidance is clear: over 1 million people now use combination inhalers to relieve symptoms and treat underlying inflammation, a significant milestone for asthma care.<sup>1<\/sup><\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>Why objective insight matters.<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">During routine asthma reviews, patients are typically asked about their symptoms, which rely on patient recall. Typically, people with asthma downplay their symptoms, believing that what they experience is typical of their condition.<sup>3<\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">And whilst peak flow remains a useful tool in asthma care, it alone may not provide the full picture. It measures airflow obstruction, rather than the inflammatory activity driving asthma, demonstrating the need for objective assessment, because better asthma care starts with better insight.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>The role of FeNO testing.<sup>2<\/sup><\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Fractional exhaled Nitric Oxide (FeNO) testing provides an objective tool to measure airway inflammation. It is non-invasive, easy to do at the point of care and supports:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Diagnosis,<\/li>\n\n\n\n<li>Inhaled corticosteroid (ICS) decisions,<\/li>\n\n\n\n<li>Adherence assessment,<\/li>\n\n\n\n<li>Monitoring,<\/li>\n\n\n\n<li>Evaluation of exacerbation risk.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Aligning with the latest guidance, FeNO supports the move towards more personalised, biomarker-driven asthma care.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>The NObreath<sup>\u00ae<\/sup> FeNO device.<\/strong><\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/www.nobreathfeno.com\/\">NObreath<sup>\u00ae<\/sup><\/a> is a modern FeNO device; it is portable and easy to use, making it perfect for primary care. Clinicians can measure a person\u2019s airway inflammation in a short amount of time, fitting perfectly into a standard healthcare appointment. This objective insight enables clinicians to make informed decisions there and then without the need for a follow-up appointment to discuss results.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Combined with an extensive clinical history, a FeNO test with the <a href=\"https:\/\/www.bedfont.com\/products\/\">NObreath<sup>\u00ae<\/sup><\/a> can aid in an asthma diagnosis and tailor treatment appropriately, providing enhanced asthma monitoring.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-left\"><strong>Precision medicine and the future of asthma care.<sup>2<\/sup><\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Guidelines are updated as technology and research evolve to improve patient care. The latest guideline from NICE\/BTS\/SIGN marked a move towards:<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"798\" height=\"533\" src=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/Screenshot-2026-02-11-152846.png\" alt=\"Taking a FeNO test with the NObreath\" class=\"wp-image-11741\" srcset=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/Screenshot-2026-02-11-152846.png 798w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/Screenshot-2026-02-11-152846-300x200.png 300w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/04\/Screenshot-2026-02-11-152846-768x513.png 768w\" sizes=\"auto, (max-width: 798px) 100vw, 798px\" \/><\/figure>\n<\/div><\/div>\n<\/div>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Precision medicine,<\/li>\n\n\n\n<li>Biomarkers<\/li>\n\n\n\n<li>Personalised pathways<\/li>\n\n\n\n<li>Earlier intervention,<\/li>\n\n\n\n<li>Better outcomes.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The move towards combination inhalers marks more than a treatment change; it represents a broader evolution in how asthma is understood and managed. Objective insight can provide clinicians with a better understanding of what is going on beneath the surface, with FeNO testing supporting this objective insight and supporting future asthma care.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As asthma care continues to evolve, understanding airway inflammation will become increasingly important in helping clinicians deliver a more personalised and proactive approach.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To learn more about the NObreath<sup>\u00ae<\/sup> device and how FeNO testing is improving patient outcomes worldwide, visit the website <a href=\"https:\/\/www.nobreathfeno.com\/\">here<\/a>.<\/p>\n\n\n\n<h4 class=\"wp-block-heading has-text-align-left\"><strong>References<\/strong><\/h4>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u201cI no longer feel asthmatic\u201d: more than a million people now using new style inhalers [Internet]. NICE website: The National Institute for Health and Care Excellence. NICE; 2026. Available from: <a href=\"https:\/\/www.nice.org.uk\/news\/articles\/-i-no-longer-feel-asthmatic-more-than-a-million-people-now-using-new-style-inhalers\">https:\/\/www.nice.org.uk\/news\/articles\/-i-no-longer-feel-asthmatic-more-than-a-million-people-now-using-new-style-inhalers<\/a><\/li>\n\n\n\n<li>National Institute for Health and Care Excellence. Overview | Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) | Guidance | NICE [Internet]. Nice.org.uk. NICE; 2024. Available from: <a href=\"https:\/\/www.nice.org.uk\/guidance\/NG245\">https:\/\/www.nice.org.uk\/guidance\/NG245<\/a><\/li>\n\n\n\n<li>Bidad N, Barnes N, Griffiths C, Horne R. Understanding patients\u2019 perceptions of asthma control: a qualitative study. European Respiratory Journal. 2018 May 17;51(6):1701346.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Almost 10 months after the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) released an updated joint guideline for asthma care and management, a major milestone has been hit. Over 1 million people are now using combination inhalers instead of relying solely on [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":11969,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[60,55],"tags":[227,8,9,157,228,168,154,155,11,13,224,156],"class_list":["post-11929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bedfont-news","category-nobreath","tag-asthma-milestone","tag-bedfont","tag-bedfont-scientific","tag-breath-analysis","tag-combination-inhaler","tag-feno","tag-feno-testing","tag-improving-asthma-care","tag-innovating-health","tag-kent-business","tag-nice-guidelines","tag-nobreath"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What the 1 million inhaler milestone reveals about asthma care<\/title>\n<meta name=\"description\" content=\"NICE have reported a major milestone in modern asthma care, with over 1 million people now using combination inhalers. How does FeNO fit?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What the 1 million inhaler milestone reveals about asthma care\" \/>\n<meta property=\"og:description\" content=\"NICE have reported a major milestone in modern asthma care, with over 1 million people now using combination inhalers. How does FeNO fit?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Bedfont Scientific Ltd.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Bedfontltd\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-29T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Article-Featured-Images-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2240\" \/>\n\t<meta property=\"og:image:height\" content=\"1260\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jemma Carter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:site\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jemma Carter\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/\"},\"author\":{\"name\":\"Jemma Carter\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/#\\\/schema\\\/person\\\/20d6eae572713673eaee5915e03dc2d3\"},\"headline\":\"Beyond symptom relief: What the 1 million inhaler milestone reveals about modern asthma care\",\"datePublished\":\"2026-05-29T09:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/\"},\"wordCount\":750,\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Article-Featured-Images-1.png\",\"keywords\":[\"Asthma milestone\",\"Bedfont\",\"Bedfont Scientific\",\"Breath analysis\",\"Combination Inhaler\",\"FeNO\",\"FeNO Testing\",\"Improving asthma care\",\"innovating health\",\"Kent business\",\"NICE guidelines\",\"NObreath\"],\"articleSection\":[\"Bedfont news\",\"NObreath\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/\",\"name\":\"What the 1 million inhaler milestone reveals about asthma care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Article-Featured-Images-1.png\",\"datePublished\":\"2026-05-29T09:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/#\\\/schema\\\/person\\\/20d6eae572713673eaee5915e03dc2d3\"},\"description\":\"NICE have reported a major milestone in modern asthma care, with over 1 million people now using combination inhalers. How does FeNO fit?\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Article-Featured-Images-1.png\",\"contentUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Article-Featured-Images-1.png\",\"width\":2240,\"height\":1260,\"caption\":\"Beyond Symptom Relief\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beyond symptom relief: What the 1 million inhaler milestone reveals about modern asthma care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/\",\"name\":\"Bedfont Scientific Ltd.\",\"description\":\"World leaders in breath analysis.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/#\\\/schema\\\/person\\\/20d6eae572713673eaee5915e03dc2d3\",\"name\":\"Jemma Carter\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g\",\"caption\":\"Jemma Carter\"},\"url\":\"https:\\\/\\\/www.bedfont.com\\\/de\\\/author\\\/jemmac\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What the 1 million inhaler milestone reveals about asthma care","description":"NICE have reported a major milestone in modern asthma care, with over 1 million people now using combination inhalers. How does FeNO fit?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/","og_locale":"de_DE","og_type":"article","og_title":"What the 1 million inhaler milestone reveals about asthma care","og_description":"NICE have reported a major milestone in modern asthma care, with over 1 million people now using combination inhalers. How does FeNO fit?","og_url":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/","og_site_name":"Bedfont Scientific Ltd.","article_publisher":"https:\/\/www.facebook.com\/Bedfontltd\/","article_published_time":"2026-05-29T09:00:00+00:00","og_image":[{"width":2240,"height":1260,"url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Article-Featured-Images-1.png","type":"image\/png"}],"author":"Jemma Carter","twitter_card":"summary_large_image","twitter_creator":"@BedfontLtd","twitter_site":"@BedfontLtd","twitter_misc":{"Verfasst von":"Jemma Carter","Gesch\u00e4tzte Lesezeit":"5\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#article","isPartOf":{"@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/"},"author":{"name":"Jemma Carter","@id":"https:\/\/www.bedfont.com\/de\/#\/schema\/person\/20d6eae572713673eaee5915e03dc2d3"},"headline":"Beyond symptom relief: What the 1 million inhaler milestone reveals about modern asthma care","datePublished":"2026-05-29T09:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/"},"wordCount":750,"image":{"@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Article-Featured-Images-1.png","keywords":["Asthma milestone","Bedfont","Bedfont Scientific","Breath analysis","Combination Inhaler","FeNO","FeNO Testing","Improving asthma care","innovating health","Kent business","NICE guidelines","NObreath"],"articleSection":["Bedfont news","NObreath"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/","url":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/","name":"What the 1 million inhaler milestone reveals about asthma care","isPartOf":{"@id":"https:\/\/www.bedfont.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#primaryimage"},"image":{"@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Article-Featured-Images-1.png","datePublished":"2026-05-29T09:00:00+00:00","author":{"@id":"https:\/\/www.bedfont.com\/de\/#\/schema\/person\/20d6eae572713673eaee5915e03dc2d3"},"description":"NICE have reported a major milestone in modern asthma care, with over 1 million people now using combination inhalers. How does FeNO fit?","breadcrumb":{"@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#primaryimage","url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Article-Featured-Images-1.png","contentUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/05\/Article-Featured-Images-1.png","width":2240,"height":1260,"caption":"Beyond Symptom Relief"},{"@type":"BreadcrumbList","@id":"https:\/\/www.bedfont.com\/de\/beyond-symptom-relief-what-the-1-million-inhaler-milestone-reveals-about-modern-asthma-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bedfont.com\/de\/"},{"@type":"ListItem","position":2,"name":"Beyond symptom relief: What the 1 million inhaler milestone reveals about modern asthma care"}]},{"@type":"WebSite","@id":"https:\/\/www.bedfont.com\/de\/#website","url":"https:\/\/www.bedfont.com\/de\/","name":"Bedfont Scientific Ltd.","description":"World leaders in breath analysis.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bedfont.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.bedfont.com\/de\/#\/schema\/person\/20d6eae572713673eaee5915e03dc2d3","name":"Jemma Carter","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g","caption":"Jemma Carter"},"url":"https:\/\/www.bedfont.com\/de\/author\/jemmac\/"}]}},"_links":{"self":[{"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/posts\/11929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/comments?post=11929"}],"version-history":[{"count":14,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/posts\/11929\/revisions"}],"predecessor-version":[{"id":11978,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/posts\/11929\/revisions\/11978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/media\/11969"}],"wp:attachment":[{"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/media?parent=11929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/categories?post=11929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bedfont.com\/de\/wp-json\/wp\/v2\/tags?post=11929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}